Wird geladen...

Endoglin inhibits prostate cancer motility via activation of the ALK2-Smad1 pathway

Endoglin is a transforming growth factor β (TGFβ) superfamily auxiliary receptor. We had previously shown that it suppressed prostate cancer (PCa) cell motility, and that its expression was lost during PCa progression. The mechanism by which endoglin inhibits PCa cell motility is unknown. Here we de...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Craft, CS, Romero, D, Vary, CPH, Bergan, RC
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2007
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2199239/
https://ncbi.nlm.nih.gov/pubmed/17496924
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.onc.1210533
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!